Anti-OX40

DRUG3 trials

Sponsors

Providence Health & Services, Ludwig Institute for Cancer Research

Conditions

Cancer of the ProstateMetastatic MelanomaMetastatic Prostate CancerProstate Cancer

Phase 1

Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer

CompletedNCT01303705

Providence Health & ServicesCancer of the Prostate, Metastatic Prostate Cancer, Prostate Cancer

Start: 2010-10-14End: 2016-07-05Updated: 2018-08-29

Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma

WithdrawnNCT01689870

Ludwig Institute for Cancer ResearchMetastatic Melanoma

Start: 2014-03-31End: 2014-08-31Updated: 2014-04-01

Phase 2

Study of Immune Responses in Patients With Metastatic Melanoma

WithdrawnNCT01416844

Providence Health & ServicesMetastatic Melanoma

Start: 2012-09-30End: 2012-09-30Updated: 2013-03-07